<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-129515</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cannabinoids: a promissing tool for the development of novel therapies</dc:title>
<dc:description xml:lang="en">Cannabinoids, lipid mediators presents in Cannabis sativa plant, have been used for medicinal purposes for centuries. In the first half of the twentieth century they were removed from medicine due to their psychoactive adverse effects and the emergence of safer drugs. Nevertheless at the end of this century the discovery of endogenous cannabinoid system and its participation in multiple basic physiological functions have attracted much attention to the researchers as possible tools in the treatment of several pathological conditions such as neurodegenerative and metabolic disorders, autoimmune diseases, glaucoma and cancer (AU)</dc:description>
<dc:creator>Fernández-Carballido, Ana María</dc:creator>
<dc:creator>Torres-Suárez, Ana Isabel</dc:creator>
<dc:creator>Fraguas-Sánchez, Ana Isabel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los cannabinoides, mediadores lipídicos presentes en la planta Cannabis sativa, han sido utilizados en medicina desde la antigüedad; retirándose del arsenal terapéutico en la primera mitad del siglo XX debido a sus efectos adversos psicoactivos y a la aparición de alternativas más seguras. No obstante el descubrimiento del sistema cannabinoide endógeno y su participación reguladora en múltiples funciones fisiológicas básicas del organismo suscitaron de nuevo a finales del siglo pasado el interés de los investigadores como posibles herramientas terapéuticas en diversas patologías como trastornos neurodegenerativos y metabólicos, enfermedades autoinmunes, glaucoma e, incluso, cáncer (AU)</dc:description>
<dc:source>An Real Acad Farm;80(3): 555-577, jul.-sept. 2014. ilus, tab</dc:source>
<dc:identifier>ibc-129515</dc:identifier>
<dc:title xml:lang="es">Cannabinoides: una prometedora herramienta para el desarrollo de nuevas terapias</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d32175^s22073</dc:subject>
<dc:subject>^d2218^s22001</dc:subject>
<dc:subject>^d2218^s22078</dc:subject>
<dc:subject>^d9562^s22057</dc:subject>
<dc:subject>^d2218^s29165</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d33354^s22057</dc:subject>
<dc:subject>^d54692^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>201409</dc:date>
</metadata>
</record>
</ibecs-document>
